Hearing Technologies

OKLAHOMA CITY, OK — Cisplatin, a widely used chemotherapy drug, has been a crucial treatment for many cancer patients, but its effectiveness often comes with a significant downside: irreversible hearing loss. Particularly pronounced in children, this side effect can drastically reduce quality of life, affecting learning and development. However, researchers at the University of Oklahoma, led by Dr. Vibhuti Agrahari,

Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hearing aid, intended

EDEN PRAIRIE, MINNESOTA – Starkey’s industry-leading Research and Development team is celebrating nearly 300 years of collective work experience in the field of artificial intelligence. Starkey’s Vice President of Advanced Development, Amit Shahar, recently joined Chief Hearing Health Officer Dave Fabry on Starkey Sound Bites to talk about the company’s journey to become the hearing industry’s leader in technology and his vision for

LYNGE, DENMARK – Signia has announced the introduction of the Signia Active Pro IX, an advanced version of its consumer earbuds that also serve as prescription-grade hearing aids. Built on the Integrated Xperience (IX) platform, this latest offering is designed to enhance conversational abilities for a wider range of users. “Signia Active Pro IX offers our HCP partners a modern,

STAFA, SWITZERLAND – Phonak, a Sonova brand, has announced the launch of Roger Unlimited, the next generation of its award-winning remote microphones, along with updates for the Roger On™ and Roger Touchscreen Mic. The new Roger Unlimited portfolio will include built-in unlimited receivers for Roger On™, Roger Select™, Roger Table Mic, and Roger Touchscreen Mic, eliminating the need for additional

HIMSA has announced the availability of Noah ES in Australia and New Zealand. Noah ES, the cloud-enabled version of Noah, ensures that patient data is always accessible, up-to-date, and secure. For more information on the benefits of Noah ES, please visit HIMSA’s website. In its first two years, Noah ES has proven to be highly reliable, with minimal downtime and

SAN DIEGO CALIFORNIA – Sony Electronics Inc., in collaboration with WS Audiology (WSA), today announced the introduction of the CRE-C20, the latest addition to its premium over-the-counter (OTC) hearing aid lineup.1 The new device features advanced sound technology, a rechargeable battery, and customizable settings. The CRE-C20 has a small, discreet design and aims to improve hearing in various situations. It combines

CHICAGO, ILLINOIS — Nature Communications has published the peer-reviewed results of Neuromod Devices’ TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) clinical trial, which evaluated Lenire, the first and only FDA-approved bimodal tinnitus treatment device. The results, detailed in the paper titled “Combining Sound with Tongue Stimulation for the Treatment of Tinnitus: A Multi-Site Single-Arm Controlled Pivotal Trial,”

Hearing Health & Technology Matters (HHTM), an online resource for hearing professionals and consumers with hearing loss, today announces the opening of the public voting period for the 5th annual Hearing Technology Innovator Awards™. Through the international awards program, HHTM honors technological innovation and achievement in the hearing industry. Categories and Awards For 2024, the awards will be conferred in

BLUFFDALE, UTAH — Listen Technologies Corporation, a leading provider of advanced wireless listening solutions for 26 years, has promoted Kevin Jewkes to chief of staff. In this new role, Jewkes serves as a trusted advisor to and proxy for Listen Technologies President and CEO Maile Keone. “The chief of staff role at Listen Technologies is integral to fostering camaraderie, consensus,